Cyrus Harmon
2023
In 2023, Cyrus Harmon earned a total compensation of $1.3M as Former Chief Research Officer and Former Chief Executive Officer at Olema Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $48,000 |
|---|---|
| Option Awards | $550,180 |
| Salary | $120,972 |
| Other | $615,678 |
| Total | $1,334,830 |
Harmon received $615.7K in other compensation, accounting for 46% of the total pay in 2023.
Harmon also received $48K in non-equity incentive plan, $550.2K in option awards and $121K in salary.
Rankings
In 2023, Cyrus Harmon's compensation ranked 905th out of 3,006 executives tracked by ExecPay. In other words, Harmon earned more than 69.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 905 out of 3,006 | 70th |
Division Manufacturing | 530 out of 1,650 | 68th |
Major group Chemicals And Allied Products | 358 out of 918 | 61st |
Industry group Drugs | 348 out of 881 | 61st |
Industry Pharmaceutical Preparations | 237 out of 637 | 63rd |
Source: SEC filing on April 26, 2024.
Harmon's colleagues
We found three more compensation records of executives who worked with Cyrus Harmon at Olema Pharmaceuticals in 2023.